Paul J. Collins

458 total citations
8 papers, 318 citations indexed

About

Paul J. Collins is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Paul J. Collins has authored 8 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Oncology and 2 papers in Hematology. Recurrent topics in Paul J. Collins's work include Immunotherapy and Immune Responses (3 papers), T-cell and B-cell Immunology (3 papers) and Immune Cell Function and Interaction (3 papers). Paul J. Collins is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), T-cell and B-cell Immunology (3 papers) and Immune Cell Function and Interaction (3 papers). Paul J. Collins collaborates with scholars based in United Kingdom, Switzerland and Belgium. Paul J. Collins's co-authors include Bernhard Moser, Francis Mussai, Claire Shannon‐Lowe, Carmela De Santo, Margaret H.L. Ng, Gary Middleton, Silvia Panetti, Livingstone Fultang, Boris Noyvert and Sarah Booth and has published in prestigious journals such as Blood, The Journal of Immunology and The FASEB Journal.

In The Last Decade

Paul J. Collins

8 papers receiving 317 citations

Peers

Paul J. Collins

IMMUN

ONCOL

MB

PRM

EPIDE

Ho S. Oh South Korea

Claire Battin Austria

Sarah Cook United States

Marie Siwicki United States

Paula Michea France

Meike Steinert Germany

Yoji Murakami Japan

Melisa Gorosito Serrán Argentina

Manprit Kaur Dhillon Singapore

Jena E. Moseman United States

Ho S. Oh South Korea

Paul J. Collins

277 ×1.3

IMMUN

206 ×1.3

ONCOL

64 ×1.0

MB

21 ×0.9

PRM

23 ×1.1

EPIDE

Citations per year, relative to Paul J. Collins Paul J. Collins (= 1×) peers Ho S. Oh

Countries citing papers authored by Paul J. Collins

Since Specialization

Citations

This map shows the geographic impact of Paul J. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Collins more than expected).

Fields of papers citing papers by Paul J. Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Collins. The network helps show where Paul J. Collins may publish in the future.

Co-authorship network of co-authors of Paul J. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Collins. A scholar is included among the top collaborators of Paul J. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Collins. Paul J. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Collins, Paul J., Mieke Metzemaekers, Max Meyrath, et al.. (2020). CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems. Frontiers in Immunology. 11. 561404–561404. 22 indexed citations

2.

Collins, Paul J., Christopher P. Fox, Hayden Pearce, et al.. (2020). Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells. Blood. 137(2). 203–215. 26 indexed citations

3.

Fultang, Livingstone, Silvia Panetti, Margaret H.L. Ng, et al.. (2019). MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers. EBioMedicine. 47. 235–246. 138 indexed citations

4.

Karki, Chitra, et al.. (2018). Disease Burden and Integreted Disease Management of Biologic Treated Psoriasis Patients with Psoriatic Arthritis in Clinical Practice: Results from Multicountry Study in EU5. Value in Health. 21. S259–S259. 1 indexed citations

5.

Collins, Paul J., Michelle L. McCully, Laura Martínez‐Muñoz, et al.. (2017). Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4. The FASEB Journal. 31(7). 3084–3097. 57 indexed citations

6.

McCully, Michelle L., Paul J. Collins, Timothy R. Hughes, et al.. (2015). Skin Metabolites Define a New Paradigm in the Localization of Skin Tropic Memory T Cells. The Journal of Immunology. 195(1). 96–104. 19 indexed citations

7.

Dai, Chen, Paola Basilico, Tiziana P. Cremona, et al.. (2015). CXCL14 Displays Antimicrobial Activity against Respiratory Tract Bacteria and Contributes to Clearance of Streptococcus pneumoniae Pulmonary Infection. The Journal of Immunology. 194(12). 5980–5989. 53 indexed citations

8.

Collins, Paul J., et al.. (2012). Increased severity of acute graft versus host disease as a result of differential expression following a homozygous gene deletion. International Journal of Immunogenetics. 40(2). 116–119. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact